NASDAQ:SMMT
Potential Price Increase for Summit Therapeutics Inc (SMMT) After Recent Insider Activity
In a filing, Summit Therapeutics Inc revealed its Director Xia Yu acquired Company’s shares for reported $10.0 million on Oct ...
The Potential Rise in the Price of Summit Therapeutics Inc (SMMT) following insiders activity
Summit Therapeutics Inc’s recent filing unveils that its Director Xia Yu acquired Company’s shares for reported $10.0 million on Oct ...
Summit Therapeutics Inc’s latest rating changes from various analysts
Summit Therapeutics Inc’s recent filing unveils that its Director Xia Yu acquired Company’s shares for reported $10.0 million on Oct ...
Summit Therapeutics Inc (SMMT) receives a Peer perform rating from Wolfe Research
In a filing, Summit Therapeutics Inc revealed its Director Xia Yu acquired Company’s shares for reported $10.0 million on Oct ...
SMMT (Summit Therapeutics Inc) may reap gains as insiders became active recently
Summit Therapeutics Inc’s filing revealed that its Director Xia Yu acquired Company’s shares for reported $10.0 million on Oct 21 ...
Taking a Closer Look At Summit Therapeutics Inc (SMMT) Following Its Recent Trade
Summit Therapeutics Inc’s recent filing unveils that its Director Xia Yu acquired Company’s shares for reported $10.0 million on Oct ...
Summit Therapeutics Inc (SMMT) may enjoy gains as insiders got busy in the recent days
Summit Therapeutics Inc’s recent filing unveils that its Director Xia Yu acquired Company’s shares for reported $10.0 million on Oct ...
